Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Giant Cell Arteritis | 26 | 2024 | 306 | 8.140 |
Why?
|
Polymyalgia Rheumatica | 7 | 2023 | 53 | 2.620 |
Why?
|
Takayasu Arteritis | 5 | 2024 | 105 | 2.220 |
Why?
|
Prednisone | 14 | 2023 | 1564 | 1.560 |
Why?
|
Vasculitis | 3 | 2024 | 522 | 1.390 |
Why?
|
Glucocorticoids | 16 | 2024 | 2163 | 1.190 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 4 | 2023 | 225 | 1.070 |
Why?
|
Rheumatology | 3 | 2023 | 615 | 0.840 |
Why?
|
Antirheumatic Agents | 5 | 2021 | 1371 | 0.730 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 4 | 2023 | 288 | 0.640 |
Why?
|
Interleukin-6 | 3 | 2023 | 3209 | 0.620 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2018 | 86 | 0.580 |
Why?
|
Arteritis | 2 | 2024 | 159 | 0.560 |
Why?
|
Polyarteritis Nodosa | 1 | 2016 | 70 | 0.510 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2015 | 16 | 0.490 |
Why?
|
Receptors, Interleukin-6 | 4 | 2020 | 225 | 0.480 |
Why?
|
Recurrence | 8 | 2024 | 8466 | 0.480 |
Why?
|
Vision Disorders | 2 | 2022 | 1088 | 0.470 |
Why?
|
Oral Ulcer | 1 | 2015 | 96 | 0.460 |
Why?
|
Behcet Syndrome | 1 | 2015 | 86 | 0.460 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2015 | 97 | 0.460 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 251 | 0.450 |
Why?
|
Antiphospholipid Syndrome | 2 | 2015 | 165 | 0.440 |
Why?
|
Lip | 1 | 2015 | 197 | 0.430 |
Why?
|
Hair Follicle | 1 | 2015 | 211 | 0.420 |
Why?
|
Calciphylaxis | 1 | 2015 | 130 | 0.420 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 194 | 0.420 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1807 | 0.380 |
Why?
|
Drug Therapy, Combination | 7 | 2021 | 6297 | 0.360 |
Why?
|
Arterial Occlusive Diseases | 1 | 2015 | 748 | 0.360 |
Why?
|
Bone Marrow | 1 | 2021 | 2907 | 0.360 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1649 | 0.320 |
Why?
|
Thromboembolism | 1 | 2015 | 996 | 0.310 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2272 | 0.270 |
Why?
|
Treatment Failure | 3 | 2021 | 2642 | 0.270 |
Why?
|
Immunologic Factors | 2 | 2013 | 1588 | 0.270 |
Why?
|
Plasmapheresis | 2 | 2023 | 206 | 0.260 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 3 | 2015 | 694 | 0.260 |
Why?
|
Plasma Exchange | 2 | 2023 | 158 | 0.260 |
Why?
|
Immunosuppressive Agents | 2 | 2023 | 4168 | 0.260 |
Why?
|
Remission Induction | 4 | 2021 | 2394 | 0.260 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2895 | 0.250 |
Why?
|
Liver | 1 | 2021 | 7531 | 0.240 |
Why?
|
Magnetic Resonance Angiography | 2 | 2024 | 1433 | 0.240 |
Why?
|
Hospital Mortality | 2 | 2017 | 5283 | 0.240 |
Why?
|
Scleritis | 2 | 2015 | 96 | 0.230 |
Why?
|
Azathioprine | 2 | 2015 | 356 | 0.220 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1863 | 0.220 |
Why?
|
Humans | 51 | 2024 | 760437 | 0.220 |
Why?
|
Inpatients | 1 | 2015 | 2545 | 0.220 |
Why?
|
Delirium | 1 | 2015 | 1667 | 0.210 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3072 | 0.210 |
Why?
|
Peroxidase | 2 | 2016 | 610 | 0.210 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4748 | 0.190 |
Why?
|
Leukoencephalopathies | 1 | 2024 | 252 | 0.190 |
Why?
|
Aged | 21 | 2024 | 168840 | 0.180 |
Why?
|
Heart Diseases | 1 | 2014 | 2785 | 0.180 |
Why?
|
Double-Blind Method | 7 | 2023 | 12320 | 0.180 |
Why?
|
Treatment Outcome | 13 | 2024 | 64591 | 0.170 |
Why?
|
Arthritis, Rheumatoid | 3 | 2024 | 3759 | 0.170 |
Why?
|
Cyclophosphamide | 2 | 2015 | 2218 | 0.170 |
Why?
|
Liver Function Tests | 1 | 2021 | 522 | 0.160 |
Why?
|
Myeloblastin | 2 | 2016 | 101 | 0.160 |
Why?
|
Middle Aged | 23 | 2024 | 220382 | 0.160 |
Why?
|
Meningitis, Aseptic | 1 | 2018 | 59 | 0.160 |
Why?
|
Sweet Syndrome | 1 | 2018 | 58 | 0.150 |
Why?
|
Acute-Phase Proteins | 1 | 2019 | 250 | 0.150 |
Why?
|
Male | 26 | 2024 | 360035 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12969 | 0.150 |
Why?
|
Female | 25 | 2024 | 391875 | 0.150 |
Why?
|
Receptors, CCR4 | 1 | 2016 | 77 | 0.140 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2016 | 84 | 0.140 |
Why?
|
Methotrexate | 1 | 2023 | 1720 | 0.140 |
Why?
|
Transcription Factors | 1 | 2016 | 12121 | 0.130 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2024 | 2163 | 0.130 |
Why?
|
Prognosis | 3 | 2024 | 29551 | 0.130 |
Why?
|
Microscopic Polyangiitis | 1 | 2015 | 46 | 0.130 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 305 | 0.130 |
Why?
|
Malignant Atrophic Papulosis | 1 | 2015 | 7 | 0.120 |
Why?
|
Folliculitis | 1 | 2015 | 25 | 0.120 |
Why?
|
Uveitis | 2 | 2018 | 395 | 0.120 |
Why?
|
Dyspnea | 1 | 2023 | 1344 | 0.120 |
Why?
|
Fibromuscular Dysplasia | 1 | 2015 | 55 | 0.120 |
Why?
|
Genital Diseases, Male | 1 | 2015 | 83 | 0.120 |
Why?
|
Lymphocyte Count | 1 | 2016 | 778 | 0.120 |
Why?
|
Panuveitis | 1 | 2014 | 33 | 0.110 |
Why?
|
Uveitis, Anterior | 1 | 2014 | 102 | 0.110 |
Why?
|
Neck Injuries | 1 | 2015 | 160 | 0.110 |
Why?
|
Bacteroidaceae Infections | 1 | 2013 | 31 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2015 | 4549 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2024 | 80430 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2019 | 814 | 0.100 |
Why?
|
Porphyromonas gingivalis | 1 | 2013 | 162 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2022 | 1874 | 0.100 |
Why?
|
Hypergammaglobulinemia | 1 | 2012 | 72 | 0.100 |
Why?
|
Disease Progression | 3 | 2020 | 13484 | 0.090 |
Why?
|
Boston | 2 | 2021 | 9326 | 0.090 |
Why?
|
Isoxazoles | 1 | 2013 | 231 | 0.090 |
Why?
|
Ultrasonography | 1 | 2024 | 5966 | 0.090 |
Why?
|
Incidence | 3 | 2021 | 21322 | 0.090 |
Why?
|
Pneumonia | 2 | 2015 | 2140 | 0.090 |
Why?
|
Cell Count | 1 | 2015 | 1834 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58859 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 907 | 0.090 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3541 | 0.090 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2015 | 464 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6475 | 0.090 |
Why?
|
Exanthema | 1 | 2015 | 504 | 0.090 |
Why?
|
Hand | 1 | 2015 | 902 | 0.090 |
Why?
|
International Classification of Diseases | 1 | 2015 | 892 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1611 | 0.080 |
Why?
|
Heterozygote | 1 | 2016 | 2798 | 0.080 |
Why?
|
Deglutition Disorders | 1 | 2015 | 627 | 0.080 |
Why?
|
Sexually Transmitted Diseases | 1 | 2015 | 662 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6765 | 0.080 |
Why?
|
Time Factors | 3 | 2021 | 39947 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10759 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15257 | 0.080 |
Why?
|
Body Composition | 1 | 2017 | 2421 | 0.070 |
Why?
|
Prospective Studies | 2 | 2023 | 54339 | 0.070 |
Why?
|
Pilot Projects | 1 | 2021 | 8611 | 0.070 |
Why?
|
Adult | 11 | 2024 | 220781 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10538 | 0.070 |
Why?
|
Comorbidity | 3 | 2018 | 10494 | 0.070 |
Why?
|
Databases, Factual | 3 | 2017 | 7948 | 0.070 |
Why?
|
Antibodies, Bacterial | 1 | 2013 | 1469 | 0.070 |
Why?
|
Risk Factors | 3 | 2021 | 74055 | 0.070 |
Why?
|
Pulmonary Fibrosis | 1 | 2010 | 505 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36362 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2015 | 1161 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1090 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 1525 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5491 | 0.060 |
Why?
|
Blood Sedimentation | 2 | 2019 | 234 | 0.060 |
Why?
|
Stroke | 2 | 2018 | 9745 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26063 | 0.060 |
Why?
|
Survival Rate | 2 | 2015 | 12698 | 0.060 |
Why?
|
Azetidines | 1 | 2024 | 140 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2247 | 0.050 |
Why?
|
Argentina | 1 | 2022 | 245 | 0.050 |
Why?
|
Young Adult | 5 | 2024 | 59068 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 285 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4700 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2016 | 10425 | 0.050 |
Why?
|
Purines | 1 | 2024 | 605 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 139 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2023 | 3822 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16585 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9598 | 0.040 |
Why?
|
Brazil | 1 | 2022 | 1224 | 0.040 |
Why?
|
Nephritis, Interstitial | 1 | 2018 | 155 | 0.040 |
Why?
|
United States | 2 | 2023 | 72202 | 0.040 |
Why?
|
Polycythemia Vera | 1 | 2018 | 160 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 10698 | 0.040 |
Why?
|
Cohort Studies | 2 | 2017 | 41366 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2017 | 678 | 0.030 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2016 | 97 | 0.030 |
Why?
|
Piperidines | 1 | 2024 | 1656 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 23953 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1973 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11453 | 0.030 |
Why?
|
Pyrazoles | 1 | 2024 | 2007 | 0.030 |
Why?
|
Pyrimidines | 1 | 2024 | 3024 | 0.020 |
Why?
|
Lung | 1 | 2010 | 9973 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30025 | 0.020 |
Why?
|
California | 1 | 2015 | 1426 | 0.020 |
Why?
|
Eye Diseases | 1 | 2016 | 655 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39078 | 0.020 |
Why?
|
Aspirin | 1 | 2022 | 3134 | 0.020 |
Why?
|
Peptides, Cyclic | 1 | 2013 | 392 | 0.020 |
Why?
|
Upper Extremity | 1 | 2015 | 656 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1336 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4849 | 0.020 |
Why?
|
Inflammation | 2 | 2024 | 10746 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2217 | 0.020 |
Why?
|
Lung Diseases | 1 | 2016 | 1909 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15820 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1654 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2016 | 2093 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3800 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2048 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1454 | 0.010 |
Why?
|
Autoantibodies | 1 | 2013 | 2123 | 0.010 |
Why?
|
Radiography | 1 | 2010 | 6963 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8216 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12932 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8527 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20078 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20551 | 0.010 |
Why?
|
Child | 1 | 2024 | 80086 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88196 | 0.010 |
Why?
|
Concepts
(192)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_